Top News
South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market
AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.
- Our Sponsors Ad -